Coombe, who also heads to 100 Group of Finance Directors, will take up his post upon completion of the £114bn merger.
The only executive casualties from SmithKline’s board were announced as chief executive Jan Leschly, who is retiring six months early, and finance director Andrew Bonfield who is stepping down.
The merger will create a company with an estimated 7.3% share of the global pharmaceutical market. The company will have a research and development budget of around £2.4bn and 40,000 employees.
Just one half of UK practices have implemented a pricing structure around auto enrolment implementation and advice - with many suffering increased costs
Deloitte's north-west Europe foray; BDO, Smith & Williamson investment paths; Shelley Stock Hutter; and Wilkins Kennedy discussed by editor Kevin Reed on our Friday Afternoon Live broadcast
Accountants should alter their perspective on auto-enrolment to maximise business opportunities, according to Eric Clapton.
Kevin Reed discusses whether new accountancy group Cogital can rival the Big Four...and its likely direction of travel